Discontinued — last reported Q2 '24

Non-Current Assets

AFS Securities

DexCom AFS Securities increased by 20.3% to $1.30B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 448.4%, from $236.80M to $1.30B.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ2 2024

How to read this metric

An increase reflects capital allocation toward investment portfolios, while a decrease may signal portfolio rebalancing or asset liquidation.

Detailed definition

Available-for-sale securities are debt or equity investments that are not classified as trading or held-to-maturity, and...

Peer comparison

Common in the investment portfolios of banks and insurance companies.

Metric ID: fin_afs_securities

Historical Data

10 periods
 Q3 '21Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$169.90M$275.60M$156.40M$217.30M$1.97B$236.80M$1.77B$1.48B$1.08B$1.30B
QoQ Change+62.2%-43.3%+38.9%+807.8%-88.0%+647.1%-16.1%-27.3%+20.3%
YoY Change-14.1%>999%+583.3%-45.3%+448.4%
Range$156.40M$1.97B
CAGR+146.9%
Avg YoY Growth+400.7%
Median YoY Growth+448.4%

Frequently Asked Questions

What is DexCom's afs securities?
DexCom (DXCM) reported afs securities of $1.30B in Q1 2026.
How has DexCom's afs securities changed year-over-year?
DexCom's afs securities increased by 448.4% year-over-year, from $236.80M to $1.30B.
What does afs securities mean?
Investments in securities that are held for potential sale and marked to fair market value.